Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 154

    1.

    Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.

    Grieco AJ, Burstein-Stein J.

    Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. No abstract available. PMID: 10979888 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.

    Brestel EP.

    Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. No abstract available. PMID: 10979887 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.

    Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS.

    Ann Intern Med. 2000 Jan 18;132(2):97-104.PMID: 10644288 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.

    Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM; Challenge-Rescue Study Group.

    Respir Med. 2004 Nov;98(11):1051-62.PMID: 15526805 [PubMed - indexed for MEDLINE]Related articles

    5.

    Montelukast and zafirlukast in asthma.

    [No authors listed]

    Drug Ther Bull. 1998 Sep;36(9):65-8. Review. No abstract available. PMID: 10194869 [PubMed - indexed for MEDLINE]Related articles

    6.

    New treatments for exercise-induced asthma.

    Hansen-Flaschen J, Schotland H.

    N Engl J Med. 1998 Jul 16;339(3):192-3. No abstract available. PMID: 9664097 [PubMed - indexed for MEDLINE]Related articles

    7.

    In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?

    Cash R, Blonski J.

    J Fam Pract. 2001 Sep;50(9):802. No abstract available. PMID: 11674917 [PubMed - indexed for MEDLINE]Related articles

    8.

    Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group.

    Villaran C, O'Neill SJ, Helbling A, van Noord JA, Lee TH, Chuchalin AG, Langley SJ, Gunawardena KA, Suskovic S, Laurenzi M, Jasan J, Menten J, Leff JA.

    J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):547-53.PMID: 10482826 [PubMed - indexed for MEDLINE]Related articles

    9.

    [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination]

    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.

    Eur Ann Allergy Clin Immunol. 2003 Nov;35(9):356-62. French. PMID: 14716965 [PubMed - indexed for MEDLINE]Related articles

    10.

    Exercise-induced asthma.

    [No authors listed]

    Health News. 1998 Aug 15;4(10):3. No abstract available. PMID: 9708040 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.

    Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.

    Chest. 2001 Apr;119(4):1021-6.PMID: 11296164 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.

    Raissy HH, Harkins M, Kelly F, Kelly HW.

    Pharmacotherapy. 2008 Mar;28(3):287-94.PMID: 18294107 [PubMed - indexed for MEDLINE]Related articles

    13.

    Leukotriene-receptor antagonists.

    Lipworth BJ.

    Lancet. 1999 Jan 2;353(9146):57-62. Review.PMID: 10023966 [PubMed - indexed for MEDLINE]Related articles

    14.

    Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.

    Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S.

    Treat Respir Med. 2005;4(2):129-38.PMID: 15813665 [PubMed - indexed for MEDLINE]Related articles

    15.

    Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.

    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.

    J Allergy Clin Immunol. 2004 Feb;113(2):245-51.PMID: 14767437 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Leukotriene antagonists--do they have a value?]

    Stey C.

    Praxis (Bern 1994). 2000 Mar 30;89(14):586-90. Review. German. PMID: 10815466 [PubMed - indexed for MEDLINE]Related articles

    17.

    Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.

    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.

    Ann Allergy Asthma Immunol. 2004 Jun;92(6):641-8.PMID: 15237766 [PubMed - indexed for MEDLINE]Related articles

    18.

    Leukotriene modifiers: new drugs, old and new reactions.

    Rosenwasser LJ.

    J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):374-5. No abstract available. PMID: 10069868 [PubMed - indexed for MEDLINE]Related articles

    19.

    New treatments for asthma: the role of leukotriene modifier agents.

    Valacer DJ.

    J Natl Med Assoc. 1999 Aug;91(8 Suppl):26S-39S. Review.PMID: 12653390 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.

    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.

    Pharmacoeconomics. 2002;20(13):909-18.PMID: 12381242 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data